Heyman RA - Search Results

1

The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer.

Rendi MH, Suh N, Lamph WW, Krajewski S, Reed JC, Heyman RA, Berchuck A, Liby K, Risingsong R, Royce DB, Williams CR, Sporn MB. Rendi MH, et al. Among authors: heyman ra. Cancer Res. 2004 May 15;64(10):3566-71. doi: 10.1158/0008-5472.CAN-04-0234. Cancer Res. 2004. PMID: 15150113

2

Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.

Suh N, Lamph WW, Glasebrook AL, Grese TA, Palkowitz AD, Williams CR, Risingsong R, Farris MR, Heyman RA, Sporn MB. Suh N, et al. Among authors: heyman ra. Clin Cancer Res. 2002 Oct;8(10):3270-5. Clin Cancer Res. 2002. PMID: 12374698

3

Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.

Bischoff ED, Gottardis MM, Moon TE, Heyman RA, Lamph WW. Bischoff ED, et al. Among authors: heyman ra. Cancer Res. 1998 Feb 1;58(3):479-84. Cancer Res. 1998. PMID: 9458093

4

Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure.

Bischoff ED, Heyman RA, Lamph WW. Bischoff ED, et al. Among authors: heyman ra. J Natl Cancer Inst. 1999 Dec 15;91(24):2118. doi: 10.1093/jnci/91.24.2118. J Natl Cancer Inst. 1999. PMID: 10601384

5

Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.

Gottardis MM, Bischoff ED, Shirley MA, Wagoner MA, Lamph WW, Heyman RA. Gottardis MM, et al. Among authors: heyman ra. Cancer Res. 1996 Dec 15;56(24):5566-70. Cancer Res. 1996. PMID: 8971154

6

The efficacy of 9-cis retinoic acid in experimental models of cancer.

Gottardis MM, Lamph WW, Shalinsky DR, Wellstein A, Heyman RA. Gottardis MM, et al. Among authors: heyman ra. Breast Cancer Res Treat. 1996;38(1):85-96. doi: 10.1007/BF01803787. Breast Cancer Res Treat. 1996. PMID: 8825126 Review.

7

Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.

Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK, Lotan R. Sun SY, et al. Among authors: heyman ra. Cancer Res. 1997 Nov 1;57(21):4931-9. Cancer Res. 1997. PMID: 9354460

8

A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice.

Shalinsky DR, Bischoff ED, Lamph WW, Zhang L, Boehm MF, Davies PJ, Nadzan AM, Heyman RA. Shalinsky DR, et al. Among authors: heyman ra. Cancer Res. 1997 Jan 1;57(1):162-8. Cancer Res. 1997. PMID: 8988059

9

Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.

Sun SY, Yue P, Mao L, Dawson MI, Shroot B, Lamph WW, Heyman RA, Chandraratna RA, Shudo K, Hong WK, Lotan R. Sun SY, et al. Among authors: heyman ra. Clin Cancer Res. 2000 Apr;6(4):1563-73. Clin Cancer Res. 2000. PMID: 10778990

10

Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.

Shalinsky DR, Bischoff ED, Gregory ML, Lamph WW, Heyman RA, Hayes JS, Thomazy V, Davies PJ. Shalinsky DR, et al. Among authors: heyman ra. Clin Cancer Res. 1996 Mar;2(3):511-20. Clin Cancer Res. 1996. PMID: 9816198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters